Iyengar Yoga (IY) may be able to increase the quality of life in patients who suffer from pulmonary…
Articles by Patrícia Silva, PhD
Bayer is presenting six abstracts on studies investigating riociguat for the treatment of pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary…
Natalie Maria Cole was destined to be famous right from her birth on February 6, 1950. Daughter of…
Galectin Therapeutics, Inc., will present an abstract, a collaboration with researchers at Augusta University titled “Galectin-3 Mediates Vascular Remodeling in Pulmonary…
Brad A. Wong of San Rafael, California, has been appointed President and CEO of the Pulmonary Hypertension Association (PHA),…
To mark World PH Day on May 5, the Pulmonary Hypertension Association (PHA) will join with 80 other groups worldwide…
Balloon pulmonary angioplasty (BPA) appears to be of multiple benefit to patients with chronic thromboembolic pulmonary hypertension (CTEPH), both in terms of hemodynamics and…
The Pulmonary Fibrosis Foundation (PFF) announced it has enrolled its first pulmonary fibrosis (PF) patient in the newly launched PFF Patient Registry, a…
Results from a retrospective study based on a claims database of U.S. patients with pulmonary embolism indicated that physicians are failing…
A scientist from the Montreal Heart Institute (MHI) recently presented the results of a Phase 2 clinical trial demonstrating …
The Committee for Medicinal Products for Human Use (CHMP), the scientific board of the European Medicines Agency (EMA),…
The Pulmonary Hypertension Association (PHA) recently announced the accreditation of two new Centers of Comprehensive Care and their inclusion…